Portfolio
ELSA manages a diversified portfolio of multiple investments in the life sciences industry. In total, the portfolio contains a number of compounds in varying development stages, all of which target multi-billion-Euro markets in the life science sector. A list of current and past investments can be found below.
AEP GmbH
Glycotope GmbH
Myelo Therapeutics GmbH
Acuros GmbH
CC-Ery GmbH
OctreoPharm Sciences GmbH
SurgicEye GmbH
Pentixapharm
Eckert & Ziegler SE
1717 Live Science Ventures
RISE Technologies GmbH
Cellsense Technologies GmbH
Avidal Vascular GmbH
Avitop GmbH
Viomedo UG
IUT Technologies GmbH